CASI Pharmaceuticals (China) Co., Ltd.
1 clinical trials · Sponsor
◉ Watch CASI Pharmaceuticals (China) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation (NCT06425276) | CASI Pharmaceuticals (China) Co., Ltd. | 2020-07-24 |
Track CASI Pharmaceuticals (China) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.